Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy

Among the various forms of migraine headaches, ophthalmoplegic migraine is an uncommon and rare form, the incidence of which is approximately 0.7 per million. It presents predominantly with headache and ophthalmoplegia. One of more cranial nerves can be affected, however the third cranial nerve is m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ case reports 2013-12, Vol.2013, p.bcr2013201718
Hauptverfasser: Shetty, Aakash, Khardenavis, Supriya, Deshpande, Anirudda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page bcr2013201718
container_title BMJ case reports
container_volume 2013
creator Shetty, Aakash
Khardenavis, Supriya
Deshpande, Anirudda
description Among the various forms of migraine headaches, ophthalmoplegic migraine is an uncommon and rare form, the incidence of which is approximately 0.7 per million. It presents predominantly with headache and ophthalmoplegia. One of more cranial nerves can be affected, however the third cranial nerve is most often affected. As a result, symptoms wise, mydriasis and ptosis are commonly seen. Patients generally recover completely within a few days or weeks, however residual deficits are known to occur in a minority of patients. One of the common generalised epilepsy syndromes is the juvenile myoclonic epilepsy (JME), its prevalence being roughly up to 10% of all patients with epilepsy. It usually begins in the second decade of life. Generalised tonic–clonic seizures myoclonic jerks absences constitute the main seizure types in JME. Studies indicate a definite association of epilepsy with migraine headaches and a significant number of migraneurs are found to be epileptic. Conversely, patients with epilepsy are two times more likely to have migraine, as compared to their first degree relatives without migraine. We report a known case of a female patient of JME having a history of classical migraine with aura presenting to us with headache and ophthalmoplegia. She was extensively evaluated to rule out other causes of isolated third cranial nerve palsy, with all the investigations being negative for any obvious cause. She was treated with non-steroidal anti-inflammatory drugs for the acute attack and was subsequently put on antimigraine medication, propranolol during her hospital stay, with which her ptosis recovered completely after 2 weeks. The patient was later started on tablet divalproex sodium, which the patient continues to take on a long-term basis, especially because of its efficacy as an antimigraine prophylaxis agent and a potent drug against JME.
doi_str_mv 10.1136/bcr-2013-201718
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3863046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1464909677</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4048-d8788fe39b25cc4185ca40025dca3e3766bada7fe06ff9c5509421e664827cc33</originalsourceid><addsrcrecordid>eNqFkc1rHCEYh6W0NCHNubci9FIK0-joqHMplNC0hUAuLfQmjvPOjltHpzqzYf_7uGwa0lziwQ983gdffwi9peQTpUxcdDZVNaHsMEmqXqBTKhtZyZb8fvlof4LOc96SMhjlirPX6KTmdSukrE9RvJnHZTR-irOHjbN4cptkXAB865YRuxy9WaDHy-hSj20ywRmPA6Qd4Nn4vMcuYIP_hHgbsDUZcBzwdt1BcB7wtI_Wx1C0MJfznPdv0KuhlMH5_XqGfl19_Xn5vbq--fbj8st11XHCVdUrqdQArO3qxlpOVWMNJ6RuemsYMClEZ3ojByBiGFrbNKTlNQUhuKqltYydoc9H77x2E_QWwpKM13Nyk0l7HY3T_98EN-pN3GmmBCNcFMGHe0GKf1fIi55ctuC9CRDXrCkXvCWHXyzo-yfoNq4plPY0lYrVigpFCnVxpGyKOScYHh5DiT7kqUue-pCnPuZZKt497uGB_5deAT4egW7aPmu7A19lqr4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1783281680</pqid></control><display><type>article</type><title>Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Shetty, Aakash ; Khardenavis, Supriya ; Deshpande, Anirudda</creator><creatorcontrib>Shetty, Aakash ; Khardenavis, Supriya ; Deshpande, Anirudda</creatorcontrib><description>Among the various forms of migraine headaches, ophthalmoplegic migraine is an uncommon and rare form, the incidence of which is approximately 0.7 per million. It presents predominantly with headache and ophthalmoplegia. One of more cranial nerves can be affected, however the third cranial nerve is most often affected. As a result, symptoms wise, mydriasis and ptosis are commonly seen. Patients generally recover completely within a few days or weeks, however residual deficits are known to occur in a minority of patients. One of the common generalised epilepsy syndromes is the juvenile myoclonic epilepsy (JME), its prevalence being roughly up to 10% of all patients with epilepsy. It usually begins in the second decade of life. Generalised tonic–clonic seizures myoclonic jerks absences constitute the main seizure types in JME. Studies indicate a definite association of epilepsy with migraine headaches and a significant number of migraneurs are found to be epileptic. Conversely, patients with epilepsy are two times more likely to have migraine, as compared to their first degree relatives without migraine. We report a known case of a female patient of JME having a history of classical migraine with aura presenting to us with headache and ophthalmoplegia. She was extensively evaluated to rule out other causes of isolated third cranial nerve palsy, with all the investigations being negative for any obvious cause. She was treated with non-steroidal anti-inflammatory drugs for the acute attack and was subsequently put on antimigraine medication, propranolol during her hospital stay, with which her ptosis recovered completely after 2 weeks. The patient was later started on tablet divalproex sodium, which the patient continues to take on a long-term basis, especially because of its efficacy as an antimigraine prophylaxis agent and a potent drug against JME.</description><identifier>ISSN: 1757-790X</identifier><identifier>EISSN: 1757-790X</identifier><identifier>DOI: 10.1136/bcr-2013-201718</identifier><identifier>PMID: 24296772</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Adult ; Analgesics - therapeutic use ; Anticonvulsants - therapeutic use ; Asia ; Epilepsy ; Female ; Headaches ; Humans ; Indian Sub-Continent ; Laboratories ; Meningitis ; Migraine ; Myoclonic Epilepsy, Juvenile - drug therapy ; Myoclonic Epilepsy, Juvenile - etiology ; Ophthalmoplegic Migraine - drug therapy ; Ophthalmoplegic Migraine - etiology ; Sodium ; Unusual Association of Diseases/Symptoms ; Valproic Acid - therapeutic use</subject><ispartof>BMJ case reports, 2013-12, Vol.2013, p.bcr2013201718</ispartof><rights>2013 BMJ Publishing Group Ltd</rights><rights>Copyright: 2013 2013 BMJ Publishing Group Ltd</rights><rights>2013 BMJ Publishing Group Ltd 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4048-d8788fe39b25cc4185ca40025dca3e3766bada7fe06ff9c5509421e664827cc33</citedby><cites>FETCH-LOGICAL-b4048-d8788fe39b25cc4185ca40025dca3e3766bada7fe06ff9c5509421e664827cc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863046/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863046/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24296772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shetty, Aakash</creatorcontrib><creatorcontrib>Khardenavis, Supriya</creatorcontrib><creatorcontrib>Deshpande, Anirudda</creatorcontrib><title>Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy</title><title>BMJ case reports</title><addtitle>BMJ Case Rep</addtitle><description>Among the various forms of migraine headaches, ophthalmoplegic migraine is an uncommon and rare form, the incidence of which is approximately 0.7 per million. It presents predominantly with headache and ophthalmoplegia. One of more cranial nerves can be affected, however the third cranial nerve is most often affected. As a result, symptoms wise, mydriasis and ptosis are commonly seen. Patients generally recover completely within a few days or weeks, however residual deficits are known to occur in a minority of patients. One of the common generalised epilepsy syndromes is the juvenile myoclonic epilepsy (JME), its prevalence being roughly up to 10% of all patients with epilepsy. It usually begins in the second decade of life. Generalised tonic–clonic seizures myoclonic jerks absences constitute the main seizure types in JME. Studies indicate a definite association of epilepsy with migraine headaches and a significant number of migraneurs are found to be epileptic. Conversely, patients with epilepsy are two times more likely to have migraine, as compared to their first degree relatives without migraine. We report a known case of a female patient of JME having a history of classical migraine with aura presenting to us with headache and ophthalmoplegia. She was extensively evaluated to rule out other causes of isolated third cranial nerve palsy, with all the investigations being negative for any obvious cause. She was treated with non-steroidal anti-inflammatory drugs for the acute attack and was subsequently put on antimigraine medication, propranolol during her hospital stay, with which her ptosis recovered completely after 2 weeks. The patient was later started on tablet divalproex sodium, which the patient continues to take on a long-term basis, especially because of its efficacy as an antimigraine prophylaxis agent and a potent drug against JME.</description><subject>Adult</subject><subject>Analgesics - therapeutic use</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Asia</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Headaches</subject><subject>Humans</subject><subject>Indian Sub-Continent</subject><subject>Laboratories</subject><subject>Meningitis</subject><subject>Migraine</subject><subject>Myoclonic Epilepsy, Juvenile - drug therapy</subject><subject>Myoclonic Epilepsy, Juvenile - etiology</subject><subject>Ophthalmoplegic Migraine - drug therapy</subject><subject>Ophthalmoplegic Migraine - etiology</subject><subject>Sodium</subject><subject>Unusual Association of Diseases/Symptoms</subject><subject>Valproic Acid - therapeutic use</subject><issn>1757-790X</issn><issn>1757-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc1rHCEYh6W0NCHNubci9FIK0-joqHMplNC0hUAuLfQmjvPOjltHpzqzYf_7uGwa0lziwQ983gdffwi9peQTpUxcdDZVNaHsMEmqXqBTKhtZyZb8fvlof4LOc96SMhjlirPX6KTmdSukrE9RvJnHZTR-irOHjbN4cptkXAB865YRuxy9WaDHy-hSj20ywRmPA6Qd4Nn4vMcuYIP_hHgbsDUZcBzwdt1BcB7wtI_Wx1C0MJfznPdv0KuhlMH5_XqGfl19_Xn5vbq--fbj8st11XHCVdUrqdQArO3qxlpOVWMNJ6RuemsYMClEZ3ojByBiGFrbNKTlNQUhuKqltYydoc9H77x2E_QWwpKM13Nyk0l7HY3T_98EN-pN3GmmBCNcFMGHe0GKf1fIi55ctuC9CRDXrCkXvCWHXyzo-yfoNq4plPY0lYrVigpFCnVxpGyKOScYHh5DiT7kqUue-pCnPuZZKt497uGB_5deAT4egW7aPmu7A19lqr4</recordid><startdate>20131202</startdate><enddate>20131202</enddate><creator>Shetty, Aakash</creator><creator>Khardenavis, Supriya</creator><creator>Deshpande, Anirudda</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131202</creationdate><title>Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy</title><author>Shetty, Aakash ; Khardenavis, Supriya ; Deshpande, Anirudda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4048-d8788fe39b25cc4185ca40025dca3e3766bada7fe06ff9c5509421e664827cc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Analgesics - therapeutic use</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Asia</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Headaches</topic><topic>Humans</topic><topic>Indian Sub-Continent</topic><topic>Laboratories</topic><topic>Meningitis</topic><topic>Migraine</topic><topic>Myoclonic Epilepsy, Juvenile - drug therapy</topic><topic>Myoclonic Epilepsy, Juvenile - etiology</topic><topic>Ophthalmoplegic Migraine - drug therapy</topic><topic>Ophthalmoplegic Migraine - etiology</topic><topic>Sodium</topic><topic>Unusual Association of Diseases/Symptoms</topic><topic>Valproic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shetty, Aakash</creatorcontrib><creatorcontrib>Khardenavis, Supriya</creatorcontrib><creatorcontrib>Deshpande, Anirudda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shetty, Aakash</au><au>Khardenavis, Supriya</au><au>Deshpande, Anirudda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy</atitle><jtitle>BMJ case reports</jtitle><addtitle>BMJ Case Rep</addtitle><date>2013-12-02</date><risdate>2013</risdate><volume>2013</volume><spage>bcr2013201718</spage><pages>bcr2013201718-</pages><issn>1757-790X</issn><eissn>1757-790X</eissn><abstract>Among the various forms of migraine headaches, ophthalmoplegic migraine is an uncommon and rare form, the incidence of which is approximately 0.7 per million. It presents predominantly with headache and ophthalmoplegia. One of more cranial nerves can be affected, however the third cranial nerve is most often affected. As a result, symptoms wise, mydriasis and ptosis are commonly seen. Patients generally recover completely within a few days or weeks, however residual deficits are known to occur in a minority of patients. One of the common generalised epilepsy syndromes is the juvenile myoclonic epilepsy (JME), its prevalence being roughly up to 10% of all patients with epilepsy. It usually begins in the second decade of life. Generalised tonic–clonic seizures myoclonic jerks absences constitute the main seizure types in JME. Studies indicate a definite association of epilepsy with migraine headaches and a significant number of migraneurs are found to be epileptic. Conversely, patients with epilepsy are two times more likely to have migraine, as compared to their first degree relatives without migraine. We report a known case of a female patient of JME having a history of classical migraine with aura presenting to us with headache and ophthalmoplegia. She was extensively evaluated to rule out other causes of isolated third cranial nerve palsy, with all the investigations being negative for any obvious cause. She was treated with non-steroidal anti-inflammatory drugs for the acute attack and was subsequently put on antimigraine medication, propranolol during her hospital stay, with which her ptosis recovered completely after 2 weeks. The patient was later started on tablet divalproex sodium, which the patient continues to take on a long-term basis, especially because of its efficacy as an antimigraine prophylaxis agent and a potent drug against JME.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>24296772</pmid><doi>10.1136/bcr-2013-201718</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1757-790X
ispartof BMJ case reports, 2013-12, Vol.2013, p.bcr2013201718
issn 1757-790X
1757-790X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3863046
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adult
Analgesics - therapeutic use
Anticonvulsants - therapeutic use
Asia
Epilepsy
Female
Headaches
Humans
Indian Sub-Continent
Laboratories
Meningitis
Migraine
Myoclonic Epilepsy, Juvenile - drug therapy
Myoclonic Epilepsy, Juvenile - etiology
Ophthalmoplegic Migraine - drug therapy
Ophthalmoplegic Migraine - etiology
Sodium
Unusual Association of Diseases/Symptoms
Valproic Acid - therapeutic use
title Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T08%3A00%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ophthalmoplegic%20migraine%20with%20isolated%20third%20cranial%20nerve%20palsy%20in%20a%20known%20case%20of%20juvenile%20myoclonic%20epilepsy&rft.jtitle=BMJ%20case%20reports&rft.au=Shetty,%20Aakash&rft.date=2013-12-02&rft.volume=2013&rft.spage=bcr2013201718&rft.pages=bcr2013201718-&rft.issn=1757-790X&rft.eissn=1757-790X&rft_id=info:doi/10.1136/bcr-2013-201718&rft_dat=%3Cproquest_pubme%3E1464909677%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1783281680&rft_id=info:pmid/24296772&rfr_iscdi=true